Capital Fund Management (CFM)’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,000
Closed -$1.48M 2724
2025
Q3
$1.48M Buy
+15,000
New +$1.49M ﹤0.01% 1912
2024
Q2
Sell
-33,700
Closed -$4.45M 2208
2024
Q1
$4.45M Sell
33,700
-51,700
-61% -$6.46M 0.01% 1101
2023
Q4
$10.4M Buy
85,400
+47,900
+128% +$5.34M 0.03% 760
2023
Q3
$4.21M Buy
+37,500
New +$4.76M 0.01% 1023
2021
Q3
Sell
-27,089
Closed -$4.23M 1829
2021
Q2
$4.23M Buy
27,089
+13,493
+99% +$2.19M 0.03% 630
2021
Q1
$2.11M Buy
+13,596
New +$2.11M 0.02% 723
2020
Q3
Sell
-15,038
Closed -$1.74M 1421
2020
Q2
$1.74M Buy
15,038
+10,609
+240% +$1.22M 0.03% 540
2020
Q1
$435K Buy
+4,429
New +$581K 0.01% 1082
2019
Q3
Sell
-14,214
Closed -$1.63M 1941
2019
Q2
$1.63M Buy
14,214
+2,781
+24% +$326K 0.01% 858
2019
Q1
$1.42M Sell
11,433
-8,652
-43% -$983K 0.01% 925
2018
Q4
$2.02M Sell
20,085
-5,459
-21% -$614K 0.02% 838
2018
Q3
$3.26M Buy
+25,544
New +$3.04M 0.02% 926
2017
Q4
Sell
-6,695
Closed -$761K 2014
2017
Q3
$761K Buy
+6,695
New +$773K 0.01% 1058
2017
Q2
Sell
-3,708
Closed -$440K 1788
2017
Q1
$440K Sell
3,708
-15,450
-81% -$1.75M ﹤0.01% 1182
2016
Q4
$1.92M Buy
19,158
+11,227
+142% +$1.2M 0.02% 773
2016
Q3
$1M Buy
7,931
+4,223
+114% +$522K 0.01% 962
2016
Q2
$433K Buy
+3,708
New +$420K ﹤0.01% 1220
2014
Q4
Sell
-7,416
Closed -$724K 1844
2014
Q3
$724K Sell
7,416
-8,652
-54% -$851K 0.01% 1031
2014
Q2
$1.62M Buy
+16,068
New +$1.57M 0.02% 801

Other funds holding ZBH

Capital Fund Management (CFM)'s ZBH Position: Q2 2023 in Review

Capital Fund Management (CFM) sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 29,406 shares — an estimated $3.8M sold.

Capital Fund Management (CFM) first reported a position in ZBH in Q4 2013 and held it in 14 quarters. The position peaked at $30.7M in Q4 2016. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • Capital Fund Management (CFM) reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 29,406 Zimmer Biomet shares in Q2 2023, an estimated $3.8M.
  • Capital Fund Management (CFM) first reported a position in Zimmer Biomet in Q4 2013 and held it in 14 quarters.
  • Capital Fund Management (CFM)'s Zimmer Biomet position peaked at $30.7M in Q4 2016.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2023, filed 14 Aug 2023.